You searched for viral vector - Page 51 of 53

News and Trends 21 Jun 2023

Nanobody company Attovia Therapeutics launches with $60M

…be engineered into a variety of valencies and half-life extension formats. So far, Alamar and Attovia Therapeutics have successfully generated Attobodies against a host of membrane, soluble and viral targets….

June 21, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 2 Apr 2025

Top biotech deals of March 2025

…its EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform, which provokes the immune system to attack cancer cells. ENaBL uses lentiviruses to deliver genetic instructions to immune cells, which program them to…

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 3 Feb 2020

CureVac Bids to Develop First mRNA Coronavirus Vaccine

…mRNA platform are especially suitable to rapidly provide a response to a viral outbreak situation like this,” stated Mariola Fotin-Mleczek, CTO of CureVac. Companies and labs around the world are…

February 3, 2020 - 2 minutesmins - By Jonathan Smith

In Depth 6 Feb 2018

CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?

…high-throughput knock-out screens to speed up target discovery. Using retroviral libraries of guide RNAs that target every gene in the genome, CRISPR can be used to generate thousands of different…

February 6, 2018 - 9 minutesmins - By Melanie De Almeida

In Depth 22 Jul 2020

Artificial Intelligence: A Superpower in the Fight Against Covid-19

…viral treatment domain. There were completely counterintuitive combination options that we have suggested, which you can never identify using only the Covid-19 data,” he added. Hydroxychloroquine, the anti-malarial drug touted…

July 22, 2020 - 8 minutesmins - By David Kirk

News and Trends 21 Feb 2017

New Immunotherapy Candidate receives FDA Fast Track Designation

…as well as viral infections. EBV infects over 90% of the population usually causing a latent infection. However, EBV-infection is connected to a variety of cancers including 15% – 20%…

February 21, 2017 - 3 minutesmins - By Melanie De Almeida

London UK venture capital adendra therapeutics apple tree partners

News and Trends 14 Dec 2021

ATP Blazes US Venture Capital Trail into European Biotech Startups

…in its portfolio, which includes companies such as Canadian kidney disease biopharmaceutical Chinook Therapeutics and non-viral gene therapy biotech Intergalactic Therapeutics. ATP has also invested in the US cardio-renal company…

December 14, 2021 - 4 minutesmins - By Anita Chakraverty

January Financial Top European Investments

News and Trends 3 Feb 2022

The Top European Biotech Investments in January 2022

Viral infection treatments, cell therapy, and artificial intelligence led biotech investments in January 2022 as the European sector took a collective breather from December’s funding frenzy. European biotech investments started…

February 3, 2022 - 3 minutesmins - By Jonathan Smith

Vaccine for honeybees from Dalan Animal Health

In Depth 26 Apr 2023

Vaccine for honeybees: a new hope for American foulbrood disease

…viral diseases, which makes finding novel methods of protecting them quite challenging. The same goes for wild bees, which are affected by habitat loss, alteration and fragmentation, pesticides, climate change,…

April 26, 2023 - 9 minutesmins - By Willow Shah-Neville

News and Trends 15 Mar 2023

Nanite receives funding to deliver genetic therapies to the lungs

…drug delivery vehicles across multiple different indications,” Kevlahan said. About Nanite Nanite is a next-generation non-viral gene delivery company developing a new class of programmable polymer nanoparticles for a range…

March 15, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 20 Nov 2020

Breakthroughs in Decentralized Testing Could Contain Covid-19

…diagnostics by developing tests that could give results in less than an hour. The approaches employed for developing each rapid Covid-19 test differ, ranging from antibody tests and viral RNA…

November 20, 2020 - 4 minutesmins - By Kostas Vavitsas

News and Trends 26 Oct 2022

Inotrem study for the treatment of critically ill COVID-19 patients meets endpoints

…TREM-1, is pathogen agnostic and has the potential to treat those very severe inflammatory conditions caused by both viral and bacterial infections.” Sven Zimmermann, CEO of Inotrem, added: “We are…

October 26, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: viral vector

Nanobody company Attovia Therapeutics launches with $60M

Top biotech deals of March 2025

CureVac Bids to Develop First mRNA Coronavirus Vaccine

CRISPR/Cas9: Could the Gene Editing Technology be the Future of Drug Discovery?

Artificial Intelligence: A Superpower in the Fight Against Covid-19

New Immunotherapy Candidate receives FDA Fast Track Designation

ATP Blazes US Venture Capital Trail into European Biotech Startups

The Top European Biotech Investments in January 2022

Vaccine for honeybees: a new hope for American foulbrood disease

Nanite receives funding to deliver genetic therapies to the lungs

Breakthroughs in Decentralized Testing Could Contain Covid-19

Inotrem study for the treatment of critically ill COVID-19 patients meets endpoints

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!